Efficacy of an innovative aerosol foam formulation of fixed combination calcipotriol plus betamethasone dipropionate in patients with psoriasis vulgaris.
about
Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam in Patients with Moderate-to-Severe Psoriasis: Sub-Group Analysis of the PSO-ABLE Study.A Novel Aerosol Foam Formulation of Calcipotriol and Betamethasone Has No Impact on HPA Axis and Calcium Homeostasis in Patients With Extensive Psoriasis Vulgaris.Superior efficacy of calcipotriene and betamethasone dipropionate aerosol foam versus ointment in patients with psoriasis vulgaris--A randomized phase II study.Supersaturation of Calcipotriene and Betamethasone Dipropionate in a Novel Aerosol Foam Formulation for Topical Treatment of Psoriasis Provides Enhanced Bioavailability of the Active Ingredients.Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam Compared with Betamethasone 17-Valerate-Medicated Plaster for the Treatment of Psoriasis.Optimizing Anti-Inflammatory and Immunomodulatory Effects of Corticosteroid and Vitamin D Analogue Fixed-Dose Combination Therapy.Calcipotriene betamethasone dipropionate aerosol foam in the treatment of plaque psoriasis: a review of the literature.Budget impact model in moderate-to-severe psoriasis vulgaris assessing effects of calcipotriene and betamethasone dipropionate foam on per-patient standard of care costs.Calcipotriol/Betamethasone Dipropionate Foam: A Review in Plaque Psoriasis.Fixed combination calcipotriol plus betamethasone dipropionate aerosol foam in the treatment of psoriasis vulgaris: rationale for development and clinical profile.Reformulations of well-known active ingredients in the topical treatment of psoriasis vulgaris can improve clinical outcomes for patients.Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam is Effective, Independent of Body Mass Index and the Extent and Severity of Psoriasis.Comparison of Occlusive and Open Application in a Psoriasis Plaque Test Design, Exemplarily Using Investigations of Mapracorat 0.1% Ointment versus Vehicle and Reference Drugs.Calcipotriol plus betamethasone dipropionate aerosol foam provides superior efficacy vs. gel in patients with psoriasis vulgaris: randomized, controlled PSO-ABLE study.Management of scalp psoriasis: current perspectives.Calcipotriol/betamethasone dipropionate aerosol foam for the treatment of psoriasis vulgaris: case series and review of the literature
P2860
Q33650112-495E5F7C-2867-419F-81CB-4992B866BFAFQ34487520-02D65289-B432-4E7F-A670-69981C679255Q36635181-74B1027E-2E9B-4D10-8054-6BD37F30A2F0Q37150168-7BFCAA12-8094-4AB5-8CC2-A38A23126BE9Q37693862-155D295D-A5EC-4E67-9996-FCA39A4DCE6EQ38635555-61A87262-8DD2-4D22-93E6-E2AB23740B86Q38704121-82FACE90-5882-4CD0-A736-6EAF8B409594Q38743710-45E62B57-3BD4-4B78-987B-FE32B2AAF676Q38963067-4D6E26F6-0BA1-4182-83D7-688075831EE1Q39034449-809FA595-E3F4-4E4E-9FB5-87AF320B1447Q39248590-C492E5FD-18E5-48F1-9EDE-A5FC883A8C67Q42364287-9C397889-2DCA-4375-9E3F-D691374F116FQ50729482-814D8875-F093-4221-8595-29933555FC57Q53034596-CB750D17-69A9-4C13-BC52-B2341F0B22AEQ54941753-ACC10C89-0BD1-408E-B3D9-015D2DDE9A50Q57816525-50143BD8-59D4-475C-A0EC-3C6AE5043B4F
P2860
Efficacy of an innovative aerosol foam formulation of fixed combination calcipotriol plus betamethasone dipropionate in patients with psoriasis vulgaris.
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Efficacy of an innovative aero ...... ients with psoriasis vulgaris.
@ast
Efficacy of an innovative aero ...... ients with psoriasis vulgaris.
@en
type
label
Efficacy of an innovative aero ...... ients with psoriasis vulgaris.
@ast
Efficacy of an innovative aero ...... ients with psoriasis vulgaris.
@en
prefLabel
Efficacy of an innovative aero ...... ients with psoriasis vulgaris.
@ast
Efficacy of an innovative aero ...... ients with psoriasis vulgaris.
@en
P2093
P2860
P1476
Efficacy of an innovative aero ...... ients with psoriasis vulgaris.
@en
P2093
Catherine Queille-Roussel
John Villumsen
Martin Olesen
P2860
P304
P356
10.1007/S40261-015-0269-7
P577
2015-04-01T00:00:00Z